Does CABAZITAXEL Cause Pulmonary embolism? 70 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 70 reports of Pulmonary embolism have been filed in association with CABAZITAXEL (Jevtana). This represents 2.7% of all adverse event reports for CABAZITAXEL.
70
Reports of Pulmonary embolism with CABAZITAXEL
2.7%
of all CABAZITAXEL reports
11
Deaths
42
Hospitalizations
How Dangerous Is Pulmonary embolism From CABAZITAXEL?
Of the 70 reports, 11 (15.7%) resulted in death, 42 (60.0%) required hospitalization, and 10 (14.3%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
Yes, Pulmonary embolism is listed as a known adverse reaction in the official FDA drug label for CABAZITAXEL.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which CABAZITAXEL Alternatives Have Lower Pulmonary embolism Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE